Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 98 (4) , 115181
Abstract
No abstract availableKeywords
All Related Versions
This publication has 15 references indexed in Scilit:
- Evaluation of the auxiliary diagnostic value of antibody assays for the detection of novel coronavirus (SARS‐CoV‐2)Journal of Medical Virology, 2020
- Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease PatientsEmerging Infectious Diseases, 2020
- Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2Journal of Clinical Microbiology, 2020
- Early Virus Clearance and Delayed Antibody Response in a Case of Coronavirus Disease 2019 (COVID-19) With a History of Coinfection With Human Immunodeficiency Virus Type 1 and Hepatitis C VirusClinical Infectious Diseases, 2020
- Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019Clinical Infectious Diseases, 2020
- Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)Clinical Infectious Diseases, 2020
- Impact of population movement on the spread of 2019-nCoV in ChinaEmerging Microbes & Infections, 2020
- Significance of serology testing to assist timely diagnosis of SARS-CoV-2 infections: implication from a family clusterEmerging Microbes & Infections, 2020
- Symposium report: One Health meets sequencingMicrobes and Infection, 2020
- Serological assays for emerging coronaviruses: Challenges and pitfallsVirus Research, 2014